NOT-AA-23-013: Notice of Participation of the NIAAA in PAR-23-191 "HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)"

Notice of Participation of the NIAAA in PAR-23-191 "HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)"

Notice Number:

NOT-AA-23-013

Key Dates

Release Date:

May 17, 2023

Related Announcements

None

Issued by

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

This Notice informs potential applicants that the National Institute on Alcohol Abuse and Alcoholism (NIAAA) is participating, effective immediately, in PAR-23-191 “HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)”.

The following text (shown in italic) has been added to reflect NIAAA's participation in this NOFO:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.273

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Kendall J. Bryant, Ph.D.
National Institute on Alcoholism and Alcohol Abuse (NIAAA)
Telephone: 301-402-0332
Email: [email protected]

Financial/Grants Management Contact(s)

Judy Fox
National Institute on Alcoholism and Alcohol Abuse (NIAAA)
Telephone: 301-443-4704
Email: [email protected]

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Kendall J. Bryant, Ph.D.
National Institute on Alcoholism and Alcohol Abuse (NIAAA)
Telephone: 301-402-0332
Email: [email protected]